Law360 (December 7, 2020, 7:02 PM EST) — A proposed class action against CBD company CV Sciences will remain paused in California federal court until regulators come around to issuing guidelines on how the popular hemp-derived compound can be marketed in edible products.
According to a minute order released Friday, U.S. District Judge Virginia A. Phillips declined to waive the stay she issued earlier this year because there was no evidence to suggest the U.S. Food and Drug Administration’s long-awaited CBD regulations weren’t forthcoming.
The plaintiffs’ „arguments are speculative and unavailing,” according to the order. „Plaintiffs’ have failed to provide any evidence supporting their statements about the FDA’s alleged…
